Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

989
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
989
Cancer Survival Analysis01:21

Cancer Survival Analysis

853
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
853
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
1.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

71
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
71

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene Expression Assay in the Management of Early Breast Cancer.

Current medicinal chemistry·2019
Same author

How to 'safely' manage delivery of a pregnant woman with congenital atrioventricular block?

Journal of cardiovascular medicine (Hagerstown, Md.)·2019
Same author

Biological Effects of Ciliary Neurotrophic Factor on hMADS Adipocytes.

Frontiers in endocrinology·2019
Same author

GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up.

Frontiers in oncology·2019
Same author

Melatonin Supplementation Decreases Hypertrophic Obesity and Inflammation Induced by High-Fat Diet in Mice.

Frontiers in endocrinology·2019
Same author

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.

PloS one·2019

Related Experiment Video

Updated: Apr 15, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K

Metformin and breast cancer: basic knowledge in clinical context.

Laura Pizzuti1, Patrizia Vici1, Luigi Di Lauro1

  • 1Division of Medical Oncology B, Regina Elena National Cancer Institute, via Elio Chianesi 53, 00144 Rome, Italy.

Cancer Treatment Reviews
|March 31, 2015
PubMed
Summary

Metformin

Keywords:
Breast cancerMetforminOutcome interpretationPopulation target

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.6K

Related Experiment Videos

Last Updated: Apr 15, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.6K

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Preclinical studies investigate metformin's molecular mechanisms in breast cancer.
  • Preclinical models do not fully capture systemic host responses, including insulin-mediated effects.
  • Metformin is widely used for dysmetabolisms and hormonal disruptions.

Purpose of the Study:

  • To bridge the gap between molecular targets and breast cancer patient characteristics.
  • To improve patient selection for metformin studies and clinical applications.
  • To enhance the interpretation and efficacy of metformin interventions in breast cancer.

Main Methods:

  • This study emphasizes the need for integrated approaches combining preclinical and clinical data.
  • Focus on patient stratification based on metabolic and hormonal profiles.
  • Utilizing systemic host response data to refine experimental design.

Main Results:

  • Systemic effects, particularly insulin-mediated changes, are crucial for understanding metformin's role in breast cancer.
  • Improved patient selection can lead to more accurate outcome interpretation.
  • Potential to identify specific breast cancer subpopulations that benefit most from metformin.

Conclusions:

  • Integrating molecular and systemic host response data is essential for optimizing metformin's use in breast cancer.
  • Targeted patient selection is key to maximizing therapeutic benefits and avoiding efficacy dilution.
  • This approach aims to better meet patient needs by refining intervention strategies.